Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

By Rajbir Singh, Sandeep Chandrashekharappa, S. Bodduluri, B. Baby, B. Hegde, Niranjan G. Kotla, Ankita A. Hiwale, T. Saiyed, Paresh Patel, M. Vijay-Kumar and 11 more. Nature Communications, 2019

609 citations recorded by the source corpus.

The importance of gut microbiota in human health and pathophysiology is undisputable. Despite the abundance of metagenomics data, the functional dynamics of gut microbiota in human health and disease remain elusive. Urolithin A (UroA), a major microbial metabolite derived from polyphenolics of berries and pomegranate fruits displays anti-inflammatory, anti-oxidative, and anti-ageing activities. Here, we show that UroA and its potent synthetic analogue (UAS03) significantly enhance gut barrier function and inhibit unwarranted inflammation. We demonstrate that UroA and UAS03 exert their barrier functions through activation of aryl hydrocarbon receptor (AhR)- nuclear factor erythroid 2–related factor 2 (Nrf2)-dependent pathways to upregulate epithelial tight junction proteins. Importantly, treatment with these compounds attenuated colitis in pre-clinical models by remedying barrier dysfunction in addition to anti-inflammatory activities. Cumulatively, the results highlight how microbial metabolites provide two-pronged beneficial activities at gut epithelium by enhancing barrier functions and reducing inflammation to protect from colonic diseases. Urolithins are microbial metabolites derived from food polyphenols. Here, Singh et al. show that urolithin A and a synthetic analogue enhance gut barrier function via Nrf2-dependent pathways and mitigate inflammation and colitis in mice, highlighting a potential application for inflammatory bowel diseases.

Subfields: Biochemistry, Nutrition and Dietetics, Plant Science

View Paper: https://www.semanticscholar.org/paper/b8520118d3aae62aaf539d233f99d1f5331c752d